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The ability of rhoptry-associated protein 1 (RAP-1) of Babesia bovis and Babesia bigemina to confer partial
protective immunity in cattle has stimulated interest in characterizing both B-cell and T-cell epitopes of these
proteins. It was previously shown that B. bovis RAP-1 associates with the merozoite surface as well as rhoptries
and expresses B-cell epitopes conserved among otherwise antigenically different B. bovis strains. An amino-
terminal 307-amino-acid domain of the molecule that is highly conserved in the B. bigemina RAP-1 homolog did
not contain cross-reactive B-cell epitopes. The studies reported here demonstrate that B. bovis RAP-1 is
strongly immunogenic for T helper (Th) cells from B. bovis-immune cattle and that like B-cell epitopes, Th-cell
epitopes are conserved in different B. bovis strains but not in B. bigemina RAP-1. Lymphocytes from cattle
immune to challenge with the Mexico strain of B. bovis proliferated against recombinant B. bovis RAP-1 protein
derived from the Mexico strain. T-cell lines established by stimulating lymphocytes with recombinant RAP-1
protein responded against B. bovis, but not B. bigemina, merozoites. T-cell lines established by repeated
stimulation of lymphocytes with B. bovis membrane antigen proliferated strongly against RAP-1, demonstrat-
ing the immunodominant nature of this protein. RAP-1-specific CD41 T cell clones recognized Mexico, Texas,
Australia, and Israel strains of B. bovis but neither B. bigeminamerozoites nor recombinant B. bigemina RAP-1.
Analysis of cytokine mRNA in RAP-1-specific Th cell clones revealed strong expression of gamma interferon
but little or no expression of interleukin-2 (IL-2), IL-4, or IL-10. Gamma interferon production was confirmed
by enzyme-linked immunosorbent assay. These results indicate the potential to use selected B. bovis RAP-1
peptides as immunogens to prime for strong, anamnestic, strain-cross-reactive type 1 immune responses upon
exposure to B. bovis.
Babesia bovis is an economically important hemoprotozoan
parasite of cattle that is prevalent in many tropical and sub-
tropical regions of the world. Vaccination of cattle with atten-
uated B. bovismerozoites derived from either infected cattle or
in vitro cultures results in protective immunity against chal-
lenge infection with both homologous and heterologous strains
(15). The feasibility of developing a successful subunit babesial
vaccine is based on the observation that immunization with
nonliving parasite extracts or highly purified proteins can in-
duce partial protection against subsequent challenge (7, 31, 40,
51).
Proteins derived from apical complex organelles, including
micronemes, spherical bodies, dense granules, and rhoptries,
are candidates for recombinant vaccines of both babesial and
related malarial parasites (16, 26, 35, 37). The existence of
these proteins as homologs in different genera of apicomplexan
parasites implies their functional relevance (35, 37, 44, 51).
These proteins, which are often soluble and secreted by the
parasite, are believed to play a major role in host erythrocyte
invasion or possibly egression (24, 37). Several apical complex
proteins of B. bovis have been described. Among these are
225-kDa (27) and 77- to 80-kDa (24, 50) spherical body pro-
teins that are also associated with the inner surface of the
infected erythrocyte membrane and the 60-kDa rhoptry-asso-
ciated protein 1 (RAP-1), which is also present on the surface
of a proportion of merozoites (20, 45). B. bovis RAP-1, also
designated T21B4 by Commins et al. and Wright and cowork-
ers (14, 51), was reported to be present in minute amounts in
the merozoite and associated with a parasite fraction contain-
ing protease activity. B. bovis RAP-1 is a member of a multi-
gene family of 58- to 60-kDa RAP-1 proteins also identified in
Babesia bigemina, Babesia bovis, and Babesia canis parasites
(17, 31, 33, 34, 43–46). Australia and cloned Mexico strains of
B. bovis express two tandem gene copies of RAP-1 (17, 43),
which in the Australia strain appear to have similar sequences
and to have arisen by gene duplication (17). Four different
gene copies of B. bigemina rap-1 were identified in a cloned
Mexico strain of B. bigemina (33, 34). The B. bovis rap-1 gene
derived from the Mexico strain encodes an open reading frame
of 565 amino acids (46). Residues 317 to 477 of B. bovis RAP-1
consist of seven tandem repeats of a degenerate 23-amino-acid
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sequence (44, 46). The carboxy-terminal 163 amino acids are
highly conserved (93% identity) between the Mexico and Aus-
tralia strains (17). Residues 1 to 307 of B. bovis RAP-1 are
highly conserved (45% identity) with residues 1 to 319 of B.
bigemina RAP-1 and include a strictly conserved 14-amino-
acid sequence (44).
Analysis of RAP-1-specific serological responses from cattle
naturally or experimentally infected with B. bovis has shown
that merozoite surface epitopes defined by monoclonal anti-
bodies (MAbs) are conserved among the Mexico, Texas, Bra-
zil, Argentina, Australia, and Israel strains of B. bovis but not
with B. bigemina (29, 36, 43). Furthermore, surface B-cell
epitopes of RAP-1 are distinct from sequences conserved be-
tween B. bovis and B. bigemina that are predicted to constitute
functional domains, including the species-conserved 14-amino-
acid sequence (45).
The ability of rhoptry-associated proteins to induce partial
protective immunity against parasite challenge was shown in
studies with Plasmodium falciparum using native (42) or re-
combinant proteins (38), with B. bovis using partially purified
native RAP-1 protein or a recombinant glutathione S-transferase
fusion protein consisting of a fragment of the B. bovis RAP-1
protein (51), and with affinity-purified native B. bigemina RAP-1
protein (31). Interestingly, in all of these studies, the titer of
specific antibody to RAP-1 did not correlate with the degree of
protective immunity, thus underscoring the importance of
characterizing CD41 T cells specific for RAP-1 and other
babesial apical complex proteins as potential effector and
helper cells relevant to the development of epitope-based vac-
cines for B. bovis.
An optimal vaccine would include peptides that contain T-
and B-cell epitopes capable of stimulating anamnestic cellular
and humoral immunity upon natural exposure to the parasite
(21). The nature of acquired resistance to challenge infection
with B. bovis is poorly defined, and little is known about either
the phenotype of the T cells responding to B. bovis or the
antigens that evoke protective T-cell responses in cattle. Be-
cause the replication of B. bovis occurs selectively within bo-
vine erythrocytes, which do not express major histocompatibil-
ity complex (MHC) antigens and therefore cannot serve as
targets of MHC-restricted cytolytic activity, we have focused
our research on characterizing antigen-specific CD41 T helper
(Th) cell responses in immune cattle against different B. bovis
antigens (7). The present study examines the memory Th cell
response against the 60-kDa B. bovis RAP-1 protein in cattle
immune to challenge infection. We demonstrate that RAP-1 is
an immunodominant antigen for Th cells from immune cattle,
that T-cell epitopes are conserved among diverse strains of B.
bovis, and that RAP-1-specific Th cell clones express type 1
cytokine profiles.
MATERIALS AND METHODS
Babesial parasite strains and cultivation. The Mexico strain of B. bovis was
originally isolated in 1978 from cattle infected with natural, tick-derived isolates
from an area of Mexico where Babesia parasites are endemic (4). The Texas
strain of B. bovis originated from an infected animal in southern Texas in 1978
(36) and was provided by Will Goff (USDA Agricultural Research Service,
Pullman, Wash.). The Australia L strain of B. bovis originated from an infected
animal in New South Wales, Australia, in 1965 (30) and was kindly provided by
Ian Wright (Commonwealth Scientific and Industrial Research Organisation,
Brisbane, Australia). The Israel strain of B. bovis was obtained from the 14th
passage of a vaccine strain. The Mexico strain of B. bigemina was obtained from
an infected animal in northeastern Mexico in 1982 (4). In vitro microaerophilous
cultures of all babesial strains were maintained in bovine erythrocytes obtained
from an uninfected donor animal (4). For use as antigen in proliferation assays,
control uninfected erythrocytes (URBC) were similarly maintained in vitro. The
percentage of parasitized erythrocytes was determined by counting giemsa-
stained cultured blood smears.
Experimental cattle. Cattle were infected with the Mexico strain of B. bovis as
described in detail elsewhere (4). Briefly, animal C15 was inoculated intrave-
nously four times over the course of 6 years with cultured, autologous infected
erythrocytes. The final inoculation of 109 parasitized erythrocytes did not evoke
a fever or a reduction in packed erythrocyte cell volume. Animal C97 was
infected by infestation with Boophilus microplus tick larvae infected with the
same strain of B. bovis. The animal recovered from clinical babesiosis following
treatment with 3 mg of diaminazine aceturate per kg of body weight and was
solidly immune to challenge infection 3 months later with an intramuscular
inoculation of a virulent, infected tick stabilate. A Babesia-naive control animal
used to assess the virulence of the stabilate became clinically ill, experiencing a
57% reduction in packed erythrocyte cell volume on day 14 postchallenge (4).
Following infection, animals C15 and C97 were serologically positive for B. bovis
(4). T cell lines specific for B. bovis (Mexico) crude membrane (CM) antigen
were established from animals C15 and C97 2 and 5 years, respectively, following
the last parasite challenge inoculation. T cell lines derived from these cattle and
stimulated with recombinant B. bovis RAP-1 antigen were established 3 and 6
years, respectively, following the last parasite challenge.
Parasite antigens. Crude parasite antigens were prepared by homogenization
of culture-derived merozoites with a French pressure cell (SLM Instruments,
Inc., Urbana, Ill.) and ultracentrifugation to yield a fraction enriched in CMs as
described previously (4). URBC were similarly fractionated for use as control
antigens. These antigens were stored at 2708C.
Recombinant B. bovis and B. bigemina RAP-1s were prepared as maltose-
binding fusion proteins as follows. The region encoding B. bovis RAP-1 was
obtained from plasmid pBv60 (44) by PCR amplification with the GeneAmp kit
(Perkin-Elmer Cetus, Norwalk, Conn.) and primers P1 and P2. Primer P1 con-
tains sequences located in the 59 end of the open reading frame of B. bovis
RAP-1 (59-ATGAGGATCCTTAGCGGCGTTGTCGGT-39), modified to in-
clude a BamHI restriction site. Primer P2 is based on a sequence present in the
multicloning site of the pBluescript vector (Stratagene, La Jolla, Calif.) (59-TT
AAGCTATAGTTCGAATAGCTAT-39) and includes a HindIII restriction site.
The pMAL-2c vector (New England Biolabs, Beverly, Mass.) and PCR products
were double digested with BamHI-HindIII and ligated as described in the man-
ufacturer’s protocol. Expression of B. bovis RAP-1 by recombinant plasmid
pMAL-60.1 was verified by Western blotting (immunoblotting) with MAb
BABB75A4 (45). Plasmid pBbg58 encoding one of the four B. bigemina rap-1
genes (Bbg-13) of the JG-29 biological clone of the Mexico strain of B. bigemina
(33, 34) was similarly amplified by PCR. Forward and reverse primer sequences
P3 and P4 are located at the 59 and 39 ends of the open reading frame of B.
bigemina RAP-1 and were modified to include a BamHI restriction site at the 59
end. Forward primer P3 consisted of 59-GCGCTCTAGAATGAGGAGCTTCT
TGGGTGTG-39, and reverse primer P4 consisted of 59-CGCGTCTAGATTAC
GCATCTGAATCATCTG-39. The PCR products were digested with BamHI
and subcloned into the pMAL-2c vector as described in the manufacturer’s
protocol. Escherichia coli XL-1 Blue (Stratagene) containing the recombinant
plasmids encoding the maltose-binding protein (MBP) or MBP fused to B. bovis
RAP-1 or B. bigemina RAP-1 were grown for 4 h at 378C in Luria broth
containing 0.2% (wt/vol) glucose under constant agitation. Protein expression
was induced with 300 mM isopropyl-b-D-thiogalactopyranoside (IPTG) for 2 h at
378C, and the cells were then harvested by centrifugation at 2,000 3 g. Pelleted
bacteria were resuspended in lysis buffer (200 mM NaCl, 1 mM EDTA, 20 mM
Tris [pH 7.4]) containing 0.5% Nonidet P-40 and submitted to one cycle of
freeze-thawing and sonication. Lysates were centrifuged for 10 min at 15,000 3
g, and the supernatants were harvested. The recombinant proteins were further
purified by affinity chromatography on amylose resin columns (New England
Biolabs) as described in the manufacturer’s protocol. The purified fusion pro-
teins were dialyzed overnight against phosphate-buffered saline (PBS) and then
stored at 2708C.
The protein concentrations in the parasite CM fractions and recombinant
proteins were determined as described previously (4).
B. bovis- and RAP-1-specific T cell lines. T cell lines reactive with B. bovis
merozoite antigens were established from animals C15 and C97 as described
previously (3). Briefly, 43 106 peripheral blood mononuclear cells (PBMC) were
cultured per well in 24-well plates (Costar, Cambridge, Mass.) in a volume of 1.5
ml of complete RPMI 1640 medium (4) with 25 mg of B. bovis CM antigen per
ml. After 7 days, the cells were subcultured to a density of 5 3 105 cells per ml
and cultured with antigen and 2 3 106 fresh irradiated (4,000 rads) autologous
PBMC as a source of antigen-presenting cells (APC). T cell lines were main-
tained for a total of 7 to 10 weeks by weekly stimulation with antigen and APC
and periodically cryopreserved in liquid nitrogen in a solution of 10% (vol/vol)
dimethyl sulfoxide in fetal bovine serum. Six weeks after initiation, the T cell line
from animal C97 was stimulated for an additional 4 weeks with 12.5 mg of
recombinant B. bovis RAP-1 per ml. Cells were assayed for antigen-dependent
proliferation 7 days following the last antigenic stimulation. Alternatively, PBMC
from these B. bovis-immune cattle were stimulated with 12.5 mg of recombinant
B. bovis RAP-1 per ml and weekly thereafter with RAP-1 for 2 to 6 weeks and
then tested for specific proliferation.
RAP-1-specific T cell clones. T cell clones were derived from a C97 T cell line
that was sequentially stimulated for 6 weeks with B. bovis CM antigen and for 2
weeks with recombinant B. bovisRAP-1 fusion protein. This cell line proliferated
to B. bovis CM and recombinant RAP-1 protein in a dose-dependent manner.
Cells were cloned by limiting dilution as described previously (6, 10) in 96-well
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round-bottom plates (Costar). Briefly, T cells were diluted to a statistical average
of 1.0 or 0.3 cells per well and stimulated with either 5 mg of recombinant RAP-1
fusion protein per ml or 25 mg of B. bovis CM antigen per ml in medium
containing 10% bovine T-cell growth factor and 5 3 104 autologous APC.
Proliferating cells were transferred successively to 48- and 24-well plates and
tested for B. bovis RAP-1 antigen-specific proliferation. The cloning frequencies
for T cells plated at 1.0 or 0.3 cells per well in the presence of RAP-1 were 23 and
10%, respectively, whereas the cloning frequencies for cells plated at 1.0 or 0.3
cells per well in the presence of B. bovis CM antigen were 9 and 5%, respectively.
Lymphocyte proliferation assays. Proliferation assays were carried out in rep-
licate wells of half-area 96-well plates (Costar) for 6 days when PBMC were used
and for 3 days when T cell lines and clones were used, essentially as described
previously (3, 4, 6). Briefly, 2 3 105 PBMC were cultured in triplicate wells with
antigen in a total volume of 100 ml of complete medium. T cell lines and clones
were assayed 7 days after the last stimulation with antigen and APC. T cells (3 3
104) were cultured in duplicate wells in a total volume of 100 ml of complete
medium containing 2 3 105 autologous or MHC-mismatched APC and antigen.
Antigens consisted of 0.2 to 25 mg of the following per ml: CM prepared from
different geographical strains of B. bovis, B. bigeminaMexico, or URBC; recom-
binant B. bovis RAP-1 fusion protein, B. bigemina RAP-1 fusion protein, or
control MBP; and freshly harvested uninfected or B. bovis Mexico-parasitized
erythrocytes. Where indicated, 2 U of human recombinant interleukin-2 (IL-2;
Boehringer Mannheim, Indianapolis, Ind.) per ml was added with antigen in the
proliferation assay. Bovine T-cell growth factor (10% vol/vol) was used as a
positive control to induce proliferation of PBMC or T cells. Irradiated, heterol-
ogous PBMC from MHC-mismatched animal C15 or G3 were used to verify
MHC restriction of the Th cell clones. To measure proliferation, cells were
radiolabeled for the last 4 to 8 h of culture with 0.25 mCi of [125I]iododeoxyuri-
dine (ICN Radiochemicals, Costa Mesa, Calif.), and radiolabeled nucleic acids
were harvested onto glass filters and counted in a gamma counter. Results are
presented as the counts per minute (cpm) of replicate cultures (mean6 standard
deviation [SD]) or as the stimulation index, which represents the mean cpm of
replicate cultures of cells plus antigen divided by the mean cpm of replicate
cultures of cells plus medium.
The one-tailed Student t test was used to determine the levels of significance
between control and experimental cultures.
Cell surface phenotypic analysis. Cell surface phenotypes of T cell lines and
clones were determined by indirect immunofluorescence and analyzed by flow
cytometry as described previously (3) by using MAbs specific for bovine CD4
(MAb IL-A12), CD8 (MAb IL-A51), CD2 (MAb IL-A26), and WC1 (MAb
IL-A29) obtained from the International Laboratory for Research on Animal
Diseases, Nairobi, Kenya.
Stimulation of cells and detection of cytokine mRNAs and gamma interferon
(IFN-g) protein. T cell clones were obtained 7 days after the last stimulation with
antigen and APC, washed twice in complete medium, and counted. On the basis
of parallel 7-day cultures of APC, residual viable APC constitute ,2% of the
starting number and ,2% of the total number of viable cells obtained from the
cultured Th cell clones, which usually undergo two cycles of replication. To
prepare RNA, T cells were stimulated for 8 h at a concentration of 2 3 106 cells
per ml with 2.5 mg of concanavalin A (ConA; Sigma Chemical Co., St. Louis,
Mo.) per ml. Total cellular RNA was prepared from the cells following lysis with
guanidinium isothiocyanate (13). As a positive control for cytokine mRNA ex-
pression, RNA was prepared from freshly isolated bovine PBMC stimulated for
18 h with ConA. For negative controls, RNA was prepared from cultures of
unstimulated murine WEHI-164 fibroblasts or from APC cultured for 7 days and
stimulated for 8 h with ConA. To confirm the integrity of RNA in each sample,
RNA was size fractionated in 1% agarose gels, and ethidium bromide-stained
gels were visualized under UV light.
To evaluate cytokine mRNA expression, a reverse transcription-PCR (RT-
PCR) assay was employed as described earlier (13, 39) with the following mod-
ifications. PCR conditions were first optimized for each cytokine by varying the
concentration of total input RNA and the number of cycles and plotting these
against the cpm in 32P-radiolabeled PCR products (13). Those RNA concentra-
tions and cycle numbers that fell on the linear portion of the plotted curve were
then selected for experimental use. Cytokine and actin cDNAs were prepared
from 0.5 mg of total RNA with a GeneAmp RNA PCR kit (Perkin-Elmer Cetus)
and as described in the manufacturer’s protocol. The bovine IL-4-specific primer
sequences were provided by Dirk Dobbelaere (University of Bern, Bern, Swit-
zerland), and the bovine IFN-g-specific primer sequences were provided by
Heng-Fong Seow, Commonwealth Scientific and Industrial Research Organisa-
tion, Parkville, Australia. Primer sequences specific for bovine b-actin, IL-2, and
IL-10 were selected from the published sequences by use of the MacVector DNA
analysis software (IBI, New Haven, Conn.). GenBank accession numbers for the
bovine cytokine or actin sequences are as follows: IL-2, M12791 (11); IL-4,
M77120 (23); IL-10, U00799 (22); IFN-g, M29867 (12); b-actin, K00622 (18).
Primers were synthesized by the Gene Technologies Laboratory, Texas A & M
University, College Station, Tex. First-strand cDNA synthesis was performed in
a thermal cycler with reverse transcriptase and reverse primers (20 to 34 pmol)
for IL-2 (59-GAGAGGCACTTAGTGATC-39; nucleotides [nt] 484 to 501), IL-4
(59-GTCTTTCAGCGTACTTGT-39; nt 406 to 423), IFN-g (59-GCTCTCCGG
CCTCGAAAGAGATT-39; nt 562 to 584), IL-10 (59-TATGTAGTTGATGAA
GATGTC-39; nt 559 to 579), and b-actin (59-ACGTAGCAGAGCTTCTCCTT
GATG-39; nt 414 to 437), with an initial 15-min incubation at 488C followed by
a 5-min incubation at 998C. Forward primers (20 to 32 pmol) for IL-2 (59-ACA
TTTGACTTTTACGTGCCCAAGGT-39; nt 198 to 223), IL-4 (59-TGCATTGT
TAGCGTCTCCT-39; nt 1 to 19), IFN-g (59-GGGCCTCTCTTCTCAGAAATT
TTG-39; nt 238 to 261), IL-10 (59-GTTGCCTGGTCTTCCTGGCTG-39; nt 98 to
118), and b-actin (59-CCTTTTACAACGAGCTGCGTGTG-39; nt 38 to 60)
were then added to the reaction mixtures, which were incubated at 958C for 4
min. Taq polymerase was added, and the mixtures were further amplified for 35
cycles under the following conditions: 958C, 1 min; 508C, 1 min; 728C, 1 min.
Each PCR product (25 ml) was then electrophoresed on a 1% agarose gel and
stained with ethidium bromide. PCR products were visualized by exposure to UV
light and photographed. The presence of specific cytokine mRNA was deter-
mined by the presence of a band with the correct product size. The potential
contribution of cytokine mRNA by residual APC in the T cell cultures is negli-
gible, since ,2% of the total viable cells were derived from APC. The specificity
of the primers and identity of the product bands were previously verified by
Southern blotting with RT-PCR products obtained from ConA-stimulated
PBMC and radiolabeled cytokine cDNA probes.
Supernatants from T cells stimulated as described above for 23 h were har-
vested by centrifugation and stored frozen at 2708C to assay for IFN-g. The
bovine IFN-g assay was performed with a commercial enzyme-linked immu-
nosorbent assay (ELISA) kit (IDEXX Laboratories, Westbrook, Maine) as de-
scribed in the manufacturer’s protocol. The IFN-g activity in culture superna-
tants diluted 1:10 or 1:50 was determined by comparison with a standard curve
obtained with a supernatant from a B. bovis-specific Th cell clone that contained
400 U of IFN-g per ml (previously determined by the neutralization of vesicular
FIG. 1. Dose-dependent proliferative responses of PBMC from B. bovis-immune cattle C15 and C97 against recombinant B. bovis RAP-1 antigen. PBMC (2 3 105)
from animals C15 (A) and C97 (B) were stimulated for 6 days with medium or 3 to 12.5 mg of antigen per ml consisting of recombinant protein B. bovis RAP-1 (closed
circles) or MBP (open circles). Cells were radiolabeled for 4 h, harvested, and counted. Results are presented as the mean 6 SD of triplicate cultures.
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stomatitis virus [9]). Positive control supernatants were obtained from PBMC
stimulated for 24 h with ConA, and negative control supernatants were obtained
from APC either cultured immediately with ConA for 24 h or cultured for 7 days
in complete medium and then cultured for an additional 24 h with ConA.
RESULTS
Proliferative responses of PBMC from B. bovis-immune cat-
tle to recombinant RAP-1 protein. Previous studies had dem-
onstrated that PBMC obtained from B. bovis-immune cattle
C15 and C97 responded reproducibly in proliferation assays
against unfractionated and fractionated membrane and soluble
forms of B. bovis merozoite antigens (4) as well as against
recombinant B. bovis proteins Bb-1 and MSA-1 (6, 10, 49). To
determine the immunogenic nature of the 60-kDa RAP-1 pro-
tein for T cells, PBMC from these immune cattle and four
uninfected control cattle were assessed for the ability to pro-
liferate against recombinant B. bovis RAP-1 expressed as a
maltose-binding fusion protein. PBMC from both immune cat-
tle responded in a dose-dependent manner to recombinant B.
bovis RAP-1 antigen, and optimal proliferation was achieved
with 3.1 to 25 mg of protein per ml (Fig. 1). Control MBP
antigen elicited a relatively weak response. PBMC from four
control cattle displayed weak proliferative responses against
both B. bovis RAP-1 fusion protein and MBP, with no detect-
able differences in the response against the two antigens (data
not presented).
Proliferative responses of T cell lines initiated and stimu-
lated with recombinant B. bovis RAP-1. When PBMC were
grown in bulk culture with RAP-1 antigen for 2 or 3 weeks and
the T cell lines were assayed for proliferation, specific prolif-
eration against RAP-1 was again observed, with maximal re-
sponses achieved with the highest dose of antigen tested (Fig.
2A and B). These cell lines also responded to B. bovis mero-
zoite CM antigen (Mexico strain), where 25 mg of protein per
ml induced responses comparable to those stimulated with 3.1
mg of recombinant B. bovis RAP-1 per ml (data not shown). In
addition, the C15 T cell line responded to merozoite CM
antigen derived from the Texas and Australia isolates of B.
bovis but did not proliferate against CM antigen prepared from
B. bigemina parasites (Fig. 2C), indicating that the RAP-1
T-cell epitopes recognized by animal C15 are conserved among
geographically diverse B. bovis isolates but not in the Mexico
isolate of B. bigemina.
To determine the type of T cell proliferating to RAP-1, cells
were phenotyped by flow cytometry with MAbs against bovine
surface markers. As observed in previous experiments with T
cell lines derived from animal C15 (2), by 8 weeks of culture,
approximately 50% of the C15 T cells expressed surface CD2
and CD4, fewer than 5% of the cells expressed CD8, and the
remaining cells expressed the WC1 antigen found on g/d T
cells. These results indicated that RAP-1 preferentially stimu-
lated proliferation of CD41 a/b T cells and g/d T cells in this
animal. The surface phenotype of the C97 line was not deter-
mined.
RAP-1 is an immunodominant antigen for B. bovis-immune
T cells. It was evident from the preceding experiments that T
FIG. 2. Dose-dependent proliferative responses of RAP-1-stimulated T cell
lines derived from B. bovis-immune cattle against recombinant RAP-1 protein or
babesial merozoite antigens. T cell lines from animals C15 (A and C) and C97
(B) were stimulated with RAP-1 for 3 (A and C) or 2 (B) weeks. (A and B) T
cells (3 3 104) were cultured for 3 days with autologous APC and medium or
antigen consisting of 0.75 to 25 mg of recombinant B. bovisRAP-1 (closed circles)
or MBP (open circles) per ml; (C) 3 3 104 T cells were cultured for 3 days with
APC and medium (MED) or a 25-mg/ml concentration of CM prepared from
URBC, the Mexico (MEX), Texas (TEX), or Australia L (AUS) strain of B.
bovis, a Mexico strain of B. bigemina (BIG), recombinant RAP-1, or MBP. Cells
were radiolabeled for 4 h, harvested, and counted. Results are presented as the
mean 6 SD of duplicate cultures.
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cells from B. bovis-infected and immune cattle expressed
strong anamnestic proliferative responses when stimulated ex
vivo with recombinant B. bovis RAP-1 protein. To further
determine the immunodominant nature of RAP-1 for T cells
from immune cattle, T cell lines from bovines C97 and C15,
which had been cultured in vitro for 2 to 7 weeks with B. bovis
merozoite CM antigen, were tested for the ability to respond to
RAP-1 antigen. In these cell lines, 94 to 99% of the cells were
CD41 T cells, and the remaining cells were CD81 T cells. We
found that at all times tested, including 7 weeks following the
initiation of culture, the T cell lines derived from both immune
animals by repeated stimulation with CM antigen recognized
recombinant B. bovis RAP-1 but neither control B. bigemina
RAP-1 nor MBP. However, CM prepared from both B. bovis
and B. bigemina merozoites induced vigorous proliferation of
the T cell lines, indicating that T cells with specificities against
additional antigens were also present in these cell lines, as
observed previously (3). Representative data from CD41 T cell
lines cultured for 5 and 6 weeks are presented in Fig. 3.
Proliferative responses of RAP-1-specific Th cell clones. To
further characterize the memory T-cell response against
RAP-1 in B. bovis-immune cattle, RAP-1-specific T cell clones
were obtained by limited dilution cloning of the RAP-1-re-
sponsive C97 T cell line that was stimulated with B. bovis
Mexico CM for 6 weeks and recombinant B. bovis RAP-1
protein for an additional 2 weeks prior to cloning. A panel of
antigen-specific clones was selected by screening for prolifer-
ation against recombinant B. bovis RAP-1, MBP, B. bovis CM,
and URBC. Twenty-seven RAP-1-specific clones were identi-
fied. All of the clones were classified as Th cells, since they
expressed CD2 and CD4 but neither CD8 nor WC1 surface
antigen. All of the clones responded in a dose-dependent man-
ner to both recombinant RAP-1 fusion protein and B. bovis
CM, and none responded to either MBP or B. bigemina RAP-1
fusion protein. Furthermore, unlike the Th cell line from which
the clones were derived (Fig. 3B), none of the clones re-
sponded to B. bigemina CM antigen. An example of the anti-
gen-driven proliferative responses with clone C97.3D2 is illus-
trated in Fig. 4. Typically, the response to recombinant RAP-1
was stronger than the response to the same concentration of B.
bovis CM (25 mg/ml), which is consistent with the observation
that RAP-1 is not an abundant molecule (51). No specific
proliferation against control antigens, including B. bigemina
CM or recombinant B. bigemina RAP-1, was observed. To-
gether with data on T cell lines, these results clearly demon-
strate that B. bovis RAP-1 T-cell epitopes are not conserved in
B. bigemina. All of the clones were MHC restricted, since none
responded to antigen in the presence of allogeneic APC de-
rived from animal C15 or G3 (data not shown). These control
studies also rule out the possibility that the RAP-1 fusion
FIG. 3. Dose-dependent proliferative responses of B. bovis Mexico CM-stimulated T cell lines derived from B. bovis-immune cattle against recombinant RAP-1
proteins or babesial merozoite antigens. T cell lines from animals C15 (A) and C97 (B) were stimulated with B. bovisMexico CM for 5 (A) or 6 (B) weeks. T cells (3 3
104) were cultured with autologous APC and medium or 1 to 25 mg of antigen per ml, which consisted of CM prepared from URBC (closed triangles), the Mexico strain
of B. bovis (closed circles), or the Mexico strain of B. bigemina (open circles) or recombinant protein B. bovis RAP-1 (closed squares) or B. bigemina RAP-1 (open
squares). Cells were radiolabeled for 4 h, harvested, and counted. Results are presented as the mean 6 SD of duplicate cultures.
FIG. 4. Proliferative response of RAP-1-specific Th cell clone C97.3D2
against recombinant RAP-1 proteins or babesial merozoite antigens. T cells (33
104) were cultured for 3 days with autologous APC and medium or 25 mg of
antigen per ml, which consisted of CM prepared from the Mexico strain of B.
bovis, the Mexico strain of B. bigemina, or recombinant protein B. bovis RAP-1,
B. bigemina RAP-1, or control MBP. Cells were radiolabeled for 4 h, harvested,
and counted. Results are presented as the mean 6 SD of duplicate cultures.
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protein has superantigenic properties for the CD41 T cell
clones.
Conservation of RAP-1 Th cell epitopes among geographi-
cally different strains of B. bovis. When the panel of Th cell
clones was tested for proliferation against geographically dis-
tinct strains of B. bovis, it was found that stimulation with
either 5 (data not shown) or 25 mg of CM per ml prepared
from merozoites of strain Mexico, Texas, Australia, or Israel
parasites induced proliferation of all clones tested (Table 1).
These results indicate that the epitope(s) recognized by this
panel of T cell clones is conserved among the four strains
tested. Although the responses against a 25-mg/ml concentra-
tion of CM derived from the Australia strain were consistently
lower than those against CM derived from the Mexico strain of
B. bovis, 5 mg of Australia CM and Mexico CM per ml induced
comparable levels of proliferation by four of five clones (data
not shown). When comparing the responses against the Mexico
and Israel strains of B. bovis, two patterns of response were
observed. Eight (30%) of 27 clones tested expressed prolifer-
ative responses against the Israel strain that were approxi-
mately 50% as strong as those directed against the Mexico
strain, whereas the remaining clones expressed similar levels of
proliferation to Israel and Mexico parasites. An example of
this dichotomous response is shown in Table 1 (experiment 2),
where the response by clone C97.1E7 to Israel parasites was
53% as strong as the response to the Mexico isolate, whereas
the responses of the other clones ranged from 90 to 121% of
the response to the Mexico isolate.
B. bovisMexico-infected erythrocytes induce proliferation by
RAP-1-specific Th cell clones. The ability of freshly harvested,
cultured, parasitized erythrocytes to induce proliferation of
three RAP-1-specific Th clones was evaluated. All clones pro-
liferated in a dose-dependent manner in response to erythro-
cytes infected with the Mexico strain of B. bovis but did not
respond to uninfected erythrocytes obtained from the same
donor. The data for these clones are presented in Fig. 5, where
FIG. 5. Dose-dependent proliferative responses of RAP-1-specific Th cell
clones against B. bovis Mexico-infected erythrocytes. T cells (3 3 104) of clones
C97.3D2 (A), C97.1E7 (B), and C97.1C10 (C) were cultured for 3 days with
autologous APC, 2 U of human IL-2 per ml, and medium or antigen consisting
of 0.1 3 106 to 5 3 106 erythrocytes that were either uninfected (closed circles)
or infected with the Mexico strain of B. bovis (open circles). Cells were radio-
labeled for 4 h, harvested, and counted. Results are presented as the mean6 SD
of duplicate cultures.
TABLE 1. Proliferative responses of B. bovis RAP-1-specific Th cell
clones against different geographical strains of B. bovis
Th cell
clone
Proliferation (SI) of clone stimulated with B. bovis straina
(% response to the Mexico strain)b
URBC Mexico Texas Australia Israel
Expt 1
C97.1C10 0.5 79.5 73.8 (93) 22.9 (29) NDc
C97.1E7 1.1 76.5 68.4 (89) 19.2 (25) ND
C97.2H2 1.1 117.4 149.1 (127) 16.3 (14) ND
C97.3D2 1.0 12.4 13.3 (107) 8.7 (70) ND
C97.4E7 1.6 21.0 28.3 (134) 16.5 (79) ND
Expt 2
C97.1C10 1.0 21.2 ND ND 23.8 (112)
C97.1E7 1.0 23.0 ND ND 12.2 (53)
C97.2H2 1.5 42.8 ND ND 51.7 (121)
C97.3D2 0.5 2.5 ND ND 3.0 (120)
C97.4E7 0.8 12.7 ND ND 11.4 (90)
a T cell clones (3 3 104) were stimulated for 3 days with 25 mg of CM per ml
prepared from URBC or the indicated parasite strains and 2 3 105 APC. The
results are presented as the stimulation index (SI): 100 3 (mean cpm [125I]
iododeoxyuridine incorporation by T cells cultured with CM antigen/mean cpm
of [125I]iododeoxyuridine incorporation by T cells cultured with medium alone).
Proliferative responses of the T cell clones cultured with parasite antigen were
shown to be significantly different from the proliferative responses of T cell
clones cultured with medium alone or URBC CM (P , 0.05) by the Student
one-tailed t test.
b Results in parentheses indicate the percentage of the response of an indi-
vidual Th cell clone to the Mexico strain.
c ND, not determined.
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cells were cultured with antigen in the presence of a low dose
of IL-2. Maximal levels of stimulation were achieved with 5 3
106 total erythrocytes per well, which represents approximately
5 3 105 parasites per well. These results demonstrate that T
cell clones that recognize both recombinant and native forms
of RAP-1 can respond to antigen presented as an infected
erythrocyte.
Cytokine expression by RAP-1-specific Th cell clones. Anal-
ysis of bovine IL-2, IL-4, IFN-g, and IL-10 mRNA expression
was performed by RT-PCR using RNA prepared from ConA-
stimulated T cells. IFN-g was also measured in the superna-
tants of cells stimulated with ConA. Cytokine mRNA expres-
sion by five clones was compared with that of ConA-stimulated
PBMC, with actin as a positive control for the presence of
intact RNA (Fig. 6). In comparison with ConA-stimulated
PBMC, the RAP-1-specific Th clones expressed undetectable
or weak levels of IL-2 (lane 1), IL-4 (lane 2), and IL-10 (lane
3) and strong levels of IFN-g (lane 4) mRNA. Even though
,2% viable APC remained after 7 days of culture, the poten-
tial contribution of cytokine mRNA by these cells was defini-
tively ruled out (Fig. 7). APC cultured with ConA expressed
actin mRNA but no detectable cytokine mRNA (Fig. 7B). In
contrast, simultaneous evaluation of RNA from ConA-stimu-
lated PBMC (Fig. 7A) and ConA-stimulated clone C97.2H2
(Fig. 7C) revealed the same cytokine profiles depicted in Fig.
6. IFN-g activity in the culture supernatants of ConA-stimu-
lated Th clones ranged from 45 to 158 U/ml (Table 2). Super-
natant from ConA-stimulated PBMC contained comparable
levels (78 U/ml) of IFN-g, whereas supernatant from APC
cultured with ConA did not contain detectable IFN-g. Because
all clones expressed relatively high levels of IFN-g and low or
undetectable levels of IL-4, they can be classified as either Th0
or Th1 cells or more broadly as type 1 Th cells (1).
DISCUSSION
Rhoptry-associated proteins of several important pathogenic
protozoa, including Plasmodium, Toxoplasma, Eimeria, and
Babesia spp., are the targets of vaccine development (16, 26,
35, 37). The ability of native and recombinant rhoptry-associ-
ated proteins of malarial and babesial parasites to confer par-
tial protection against challenge infection (26, 31, 51) has
prompted an interest in identifying both B-cell (25, 43) and
T-cell (39) epitopes on RAP-1 proteins of B. bovis and B.
bigemina parasites.
Identification of merozoite antigens that induce a Th cell
response against B. bovis and characterization of the cytokines
produced by the Th cells are important considerations for
vaccine development for this parasite (7). Studies with related
babesial and malarial parasite infections in mice have shown
that CD41 T cells are required for resolution of the erythro-
cytic stage of infection (7, 47). In addition to providing help for
antibody-producing B cells, CD41 T cells can act directly as
effector cells against intracellular protozoa. Type 1 Th cells
produce IFN-g and lymphotoxin that activate macrophages
and neutrophils to kill intraerythrocytic parasites via the pro-
duction of toxic oxygen and nitrogen metabolites (28, 47). In
malaria-infected mice, IFN-g production is dependent on
IL-12 produced by activated macrophages (41). Murine Th1
cells can also produce nitric oxide in response to malarial
antigen (48). As demonstrated for malaria, we hypothesize that
type 1 responses will be required to resolve B. bovis para-
sitemia. Furthermore, proteins that stimulate type 1 recall re-
sponses during in vivo exposure to native parasite antigen are
predicted to be protective immunogens (7). The results re-
FIG. 6. Analysis of cytokine mRNA expression in B. bovis RAP-1-specific Th
cell clones by RT-PCR. RT-PCR was performed with total cellular RNA pre-
pared from ConA-stimulated PBMC (positive control) and five Th cell clones as
indicated under each gel. Primers specific for bovine IL-2 (lane 1), IL-4 (lane 2),
IL-10 (lane 3), IFN-g (lane 4), and b-actin (lane 5) were used. The amplified
PCR products were electrophoresed on agarose gels, stained with ethidium
bromide, visualized, and photographed under UV light. The sizes of the ampli-
fied PCR products are as follows: IL-2, 304 bp; IL-4, 423 bp; IL-10, 482 bp;
IFN-g, 347 bp; b-actin, 400 bp. Markers (M), consisting of a 1-kb DNA ladder
(far left lane) and l HindIII (next left lane), were included in each gel.
FIG. 7. Analysis of cytokine mRNA expression in ConA-stimulated APC.
RT-PCR was performed with total cellular RNA prepared from lymphocytes
cultured with ConA. Lymphocytes included freshly obtained PBMC (A), irradi-
ated PBMC as a source of APC cultured for 7 days (B), and clone C97.2H2
cultured for 7 days with B. bovis RAP-1 antigen and APC (C). Primers specific
for bovine IL-2 (lane 1), IL-4 (lane 2), IL-10 (lane 3), IFN-g (lane 4), and b-actin
(lane 5) were used. The amplified PCR products were electrophoresed on aga-
rose gels, stained with ethidium bromide, visualized, and photographed under
UV light. The sizes of the amplified PCR products are as follows: IL-2, 304 bp;
IL-4, 423 bp; IL-10, 482 bp; IFN-g, 347 bp; b-actin, 400 bp. Molecular weight
markers (M), consisting of a 1-kb DNA ladder, were included in each gel and are
indicated at the left of each figure.
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ported in this paper demonstrate, for the first time, the immu-
nodominant nature of B. bovis RAP-1 for CD41 type 1 Th cells
from B. bovis-immune cattle and provide a rationale for in-
cluding RAP-1 Th-cell epitopes in a subunit vaccine for B.
bovis.
Previous reports from our laboratory have described recall
proliferative responses from B. bovis-immune animals C15 and
C97 against recombinant B. bovis spherical body protein Bb-1
and merozoite surface protein MSA-1 (6, 10, 49). In both
studies, PBMC responded specifically to these antigens, and T
cell lines were established by stimulating T cells with recom-
binant protein. However, T cell lines derived by stimulation
with crude merozoite antigens that were verified by immuno-
blot analysis to contain MSA-1 and Bb-1 proteins were unre-
sponsive in proliferation assays to MSA-1 or Bb-1 proteins (6,
49). In contrast, recombinant B. bovis RAP-1 induced strong
proliferative responses by similar merozoite antigen-derived T
cell lines established from these animals and cultured for up to
7 weeks, indicating the immunodominant nature of this anti-
gen. Although only two animals were included in this analysis,
we know that these cattle do not share MHC class II alleles
capable of presenting either RAP-1 or other B. bovis antigens
(3, 6, 10), showing that this unusual predominant response to
RAP-1 is not due to a unique MHC class II allele shared by
these particular cattle.
Another important characteristic of the Th cell response to
RAP-1 is that memory T cells from cattle exposed to the native
form of RAP-1 by infection with B. bovis clearly recognize the
recombinant antigen. This finding implies that the converse
will be true, i.e., that T cells from animals immunized with
recombinant RAP-1 protein will recognize the native protein
upon in vivo exposure to parasites. This is in fact suggested by
one study reported by Wright and colleagues (51), where im-
munization with a recombinant fragment of B. bovis RAP-1
fused to glutathione S-transferase conferred partial protection,
in the form of reduced parasitemias, upon challenge with vir-
ulent B. bovis. T-cell responses were not evaluated in this
study, and the nature of the protective response was not elu-
cidated. However, it was reported that protection was inversely
related to antibody titer, implicating a role of non-antibody
immune mechanisms. In addition, we demonstrated that Th
cell clones stimulated with recombinant B. bovis RAP-1 pro-
tein proliferated against soluble and membrane forms of mer-
ozoite antigen and cultured, parasitized erythrocytes. These
findings show that APC are capable of processing and present-
ing the relevant peptides from both recombinant and native
forms of RAP-1 protein that constitute a T-cell epitope(s).
Together, these results argue for the potential use of recom-
binant RAP-1 protein or peptides as a component in a vaccine
that could prime cattle for specific recall responses upon ex-
posure to natural B. bovis infection.
The cytokine mRNA profiles of the Th cell clones respond-
ing to RAP-1 showed that the cells expressed little IL-4 and
strong levels of IFN-g mRNA following ex vivo stimulation.
Consistent with this finding, high levels of IFN-g were secreted
by the T cells. Type 1 cytokine mRNA profiles were also
expressed by B. bovis-specific Th cell clones reactive with Bb-1
(10), MSA-1 (6), or undefined antigens (8), as well as by B.
bigemina RAP-1-specific Th cell clones (39). Although it re-
mains to be determined whether immunization with recombi-
nant B. bovisRAP-1 in an appropriate adjuvant (such as IL-12)
will stimulate type 1 responses, the finding that cloned memory
T cells specific for the native protein are type 1 Th cells is
predictive of the ability of recombinant protein to induce a
similar response.
A final important feature of the T-cell response to RAP-1 is
that the immunodominant T-cell epitope(s) is conserved
among diverse geographical strains. T cell lines or clones de-
rived from both immune cattle responded to the Texas and
Australia L strains and the Israel vaccine strain of B. bovis in
addition to the immunizing Mexico strain. Several additional
Israel strains of B. bovis were tested and found to similarly
stimulate proliferation of the Th clones (data not shown). The
conservation of both B-cell (36) and Th-cell epitopes in RAP-1
proteins from different strains of B. bovis is advantageous for
developing a vaccine that would provide protection against
challenge with heterologous parasite strains. Interestingly, the
strictly conserved 14-amino-acid sequence shared by B. bovis
and B. bigemina RAP-1 homologs was not immunogenic for T
cells in this study, supporting the contention that conserved
epitopes potentially required for parasite function are poorly
immunogenic and therefore permissive for parasite survival
(32, 35, 45).
Although T-cell epitopes recognized by both of the immune
cattle are conserved among the different strains of B. bovis
examined, reduced proliferation to Australia L and Israel
strains by several of the clones may indicate that individual T
cell clones recognize different epitopes. In support of this pos-
sibility, we previously showed that B. bovis-specific T cell
clones could be categorized into seven groups on the basis of
differential responses to different parasite strains and fraction-
ated proteins. T cell clones from each group recongized dif-
ferent antigens (5). Furthermore, a dichotomous response in
the level of proliferation to different strains of B. bigemina by
B. bigemina RAP-1-specific Th clones correlated with the rec-
ognition of distinct T-cell epitopes (25, 39). Sequence variation
in a T-cell epitope expressed by the two gene copies of B. bovis
RAP-1 could explain our results, if the copies were differen-
tially expressed in the different strains. Alternatively, limited
sequence variation in a T-cell epitope could result in reduced
proliferative responses (19). Future experiments will identify
the B. bovisRAP-1 T-cell epitope(s) and determine the level of
expression and possible sequence variation of the T-cell
epitopes encoded by the two gene copies of B. bovis RAP-1 in
the different parasite strains.
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TABLE 2. Production of IFN-g by B. bovis RAP-1-specific
Th cell clones
Lymphocytesa IFN-g(U/ml)b
Th cell clones
C97.1C10 ........................................................................................ 75
C97.1E7 .......................................................................................... 125
C97.2H2.......................................................................................... 158
C97.3D2.......................................................................................... 45
C97.4E7 .......................................................................................... 131
PBMC
Fresh PBMC .................................................................................. 78
Fresh APC...................................................................................... 0
7-Day APC..................................................................................... 0
a Th cells were cultured for 23 to 24 h at a density of 2 3 106 cells per ml in
complete RPMI 1640 medium with 2.5 mg of ConA per ml. Freshly isolated
PBMC or irradiated PBMC (APC) were cultured at 2 3 106 cells per ml with 2.5
mg of ConA per ml either immediately (fresh) or after 7 days of culture.
b IFN-g levels were determined with a bovine IFN-g-specific ELISA
(IDEXX), by use of a standard bovine IFN-g supernatant containing 400 U/ml.
3348 BROWN ET AL. INFECT. IMMUN.
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
This research was supported by the U.S. Department of Agriculture-
US-Israel-BARD grants US-1855-90R and US-2496-94C, the National
Institutes of Health grant AI30136, and USDA NRICGP grants 92-
37204-8180 and 93-37206-9075.
REFERENCES
1. Bloom, B. R., P. Salgame, and B. Diamond. 1992. Revisiting and revising
suppressor T cells. Immunol. Today 13:131–136.
2. Brown, W. C., W. C. Davis, S. H. Choi, D. A. E. Dobbelaere, and G. A.
Splitter. 1994. Functional and phenotypic characterization of WC11 g/d T
cells isolated from Babesia bovis-stimulated T cell lines. Cell. Immunol.
153:9–27.
3. Brown, W. C., and K. S. Logan. 1992. Babesia bovis: bovine helper T cell lines
reactive with soluble and membrane antigens of merozoites. Exp. Parasitol.
74:188–199.
4. Brown, W. C., K. S. Logan, G. G. Wagner, and C. L. Tetzlaff. 1991. Cell-
mediated immune responses to Babesia bovis merozoite antigens in cattle
following infection with tick-derived or cultured parasites. Infect. Immun.
59:2418–2426.
5. Brown, W. C., K. S. Logan, S. Zhao, D. K. Bergman, and A. C. Rice-Ficht.
1995. Identification of Babesia bovis merozoite antigens separated by con-
tinuous-flow electrophoresis that stimulate proliferation of helper T-cell
clones derived from B. bovis-immune cattle. Infect. Immun. 63:3106–3116.
6. Brown, W. C., G. H. Palmer, T. F. McElwain, S. A. Hines, and D. A. E.
Dobbelaere. 1993. Babesia bovis: characterization of the T helper cell re-
sponse against the 42-kDa merozoite surface antigen (MSA-1) in cattle. Exp.
Parasitol. 79:97–110.
7. Brown, W. C., and A. C. Rice-Ficht. 1994. Use of helper T cells to identify
potentially protective antigens of Babesia bovis. Parasitol. Today 10:145–149.
8. Brown, W. C., V. M. Woods, D. A. E. Dobbelaere, and K. S. Logan. 1993.
Heterogeneity in cytokine profiles of Babesia bovis-specific bovine CD41 T
cell clones activated in vitro. Infect. Immun. 61:3273–3281.
9. Brown, W. C., S. Zhao, A. C. Rice-Ficht, K. S. Logan, and V. M. Woods. 1992.
Bovine helper T cell clones recognize five distinct epitopes on Babesia bovis
merozoite antigens. Infect. Immun. 60:4364–4372.
10. Brown, W. C., S. Zhao, V. M. Woods, C. A. Tripp, C. L. Tetzlaff, V. T.
Heussler, D. A. E. Dobbelaere, and A. C. Rice-Ficht. 1993. Identification of
two Th1 cell epitopes on the Babesia bovis-encoded 77-kilodalton merozoite
protein (Bb-1) by use of truncated recombinant fusion proteins. Infect.
Immun. 61:236–244.
11. Cerretti, D. P., K. McKereghan, A. Larsen, M. A. Cantrell, D. Anderson, S.
Gillis, D. Cosman, and P. E. Baker. 1986. Cloning, sequence, and expression
of bovine interleukin 2. Proc. Natl. Acad. Sci. USA 83:3223–3227.
12. Cerretti, D. P., K. McKereghan, A. Larsen, D. Cosman, S. Gillis, and P. E.
Baker. 1986. Cloning, sequence, and expression of bovine interferon-gamma.
J. Immunol. 136:4561–4564.
13. Chitko-McKown, C. G., B. J. Ruef, A. C. Rice-Ficht, and W. C. Brown. 1995.
Interleukin-10 downregulates proliferation and expression of interleukin-2
receptor p55 chain and interferon-g, but not interleukin-2 or interleukin-4,
by parasite-specific helper T cell clones obtained from cattle chronically
infected with Babesia bovis or Fasciola hepatica. J. Interferon Cytokine Res.
15:915–922.
14. Commins, M. A., B. V. Goodger, and I. G. Wright. 1985. Proteinases in the
lysate of bovine erythrocytes infected with Babesia bovis: initial vaccination
studies. Int. J. Parasitol. 15:491–495.
15. Dalrymple, B. P. 1992. Diversity and selection in Babesia bovis and their
impact on vaccine use. Parasitol. Today 8:21–23.
16. Dalrymple, B. P. 1993. Molecular variation and diversity in candidate vaccine
antigens from Babesia. Acta Trop. 53:227–238.
17. Dalrymple, B. P., R. E. Casu, J. M. Peters, C. M. Dimmock, K. R. Gale, R.
Boese, and I. G. Wright. 1993. Characterisation of a family of multi-copy
genes encoding rhoptry protein homologues in Babesia bovis, Babesia bovis
and Babesia canis. Mol. Biochem. Parasitol. 57:181–192.
18. Degen, J. L., M. G. Neubauer, S. J. Friezner Degen, C. E. Seyfried, and D. R.
Morris. 1983. Regulation of protein synthesis in mitogen-activated bovine
lymphocytes. Analysis of actin-specific and total mRNA accumulation and
utilization. J. Biol. Chem. 258:12153–12162.
19. Evavold, B. D., J. Sloan-Lancaster, and P. M. Allen. 1993. Tickling the TCR:
selective T-cell functions stimulated by altered peptide ligands. Immunol.
Today 14:602–609.
20. Goff, W. L., W. C. Davis, G. H. Palmer, T. F. McElwain, W. C. Johnson, J. F.
Bailey, and T. C. McGuire. 1988. Identification of Babesia bovis merozoite
surface antigens by using immune bovine sera and monoclonal antibodies.
Infect. Immun. 56:2363–2368.
21. Good, M. F., and L. H. Miller. 1990. T-cell antigens and epitopes in malaria
vaccine design. Curr. Top. Microbiol. Immunol. 155:65–78.
22. Hash, S. M., W. C. Brown, and A. C. Rice-Ficht. 1994. Characterization of a
cDNA encoding bovine interleukin-10: kinetics of expression in bovine lym-
phocytes. Gene 139:257–261.
23. Heussler, V. T., M. Eichorn, and D. A. E. Dobbelaere. 1992. Cloning of a
full-length cDNA encoding bovine IL-4 by the polymerase chain reaction.
Gene 114:273–278.
24. Hines, S. A., G. H. Palmer, W. C. Brown, T. F. McElwain, C. E. Suarez, O.
Vidotto, and A. C. Rice-Ficht. 1995. Genetic and antigenic characterization
of Babesia bovis merozoite spherical body protein Bb-1. Mol. Biochem.
Parasitol. 69:149–159.
25. Ho¨tzel, I., W. C. Brown, T. F. McElwain, S. D. Rodriguez, and G. H. Palmer.
1996. Dimorphic sequences of rap-1 genes encode B and CD41 T helper
lymphocyte epitopes in the Babesia bigemina rhoptry associated protein-1.
Mol. Biochem. Parasitol., in press.
26. Howard, R. J., and B. L. Pasloske. 1993. Target antigens for asexual malaria
vaccine development. Parasitol. Today 9:369–372.
27. Jasmer, D. P., D. W. Reduker, L. E. Perryman, and T. C. McGuire. 1991. A
Babesia bovis 225-kilodalton protein located on the cytoplasmic side of the
erythrocyte membrane has sequence similarity with a region of glycogen
phosphorylase. Mol. Biochem. Parasitol. 52:263–270.
28. Kumaritalake, L. M., A. Ferrante, and C. Rzepczyk. 1991. The role of T
lymphocytes in immunity to Plasmodium falciparum. Enhancement of neu-
trophil-mediated parasite killing by lymphotoxin and IFN-g: comparisons
with tumor necrosis factor effects. J. Immunol. 146:762–767.
29. Madruga, C., C. E. Suarez, T. F. McElwain, and G. H. Palmer. 1996. Con-
servation of merozoite membrane and apical complex B cell epitopes among
Babesia bigemina and Babesia bovis strains isolated in Brazil. Vet. Parasitol.
61:21–30.
30. Mahoney, D. F., and I. G. Wright. 1976. Babesia argentina: immunization of
cattle with a killed antigen against infection with a heterologous strain. Vet.
Parasitol. 2:273–306.
31. McElwain, T. F., L. E. Perryman, A. J. Musoke, and T. C. McGuire. 1991.
Molecular characterization and immunogenicity of neutralization-sensitive
Babesia bigemina merozoite surface proteins. Mol. Biochem. Parasitol. 47:
213–222.
32. Miller, L. H., M. F. Good, and G. Milon. 1994. Malaria pathogenesis. Science
264:1878–18883.
33. Mishra, V. S., T. F. McElwain, J. B. Dame, and E. B. Stephens. 1992.
Isolation, sequence, and differential expression of the p58 gene family of
Babesia bigemina. Mol. Biochem. Parasitol. 53:149–158.
34. Mishra, V. S., E. B. Stephens, J. B. Dame, L. E. Perryman, T. C. McGuire,
and T. F. McElwain. 1991. Immunogenicity and sequence analysis of re-
combinant p58: a neutralization-sensitive, antigenically conserved Babesia
bigemina merozoite surface protein. Mol. Biochem. Parasitol. 47:207–
212.
35. Palmer, G. H., and T. F. McElwain. 1995. Molecular basis for vaccine
development against anaplasmosis and babesiosis. Vet. Parasitol. 57:233–
253.
36. Palmer, G. H., T. F. McElwain, L. E. Perryman, W. C. Davis, D. R. Reduker,
D. P. Jasmer, V. Shkap, E. Pipano, W. L. Goff, and T. C. McGuire. 1991.
Strain variation of Babesia bovis merozoite surface-exposed epitopes. Infect.
Immun. 59:3340–3342.
37. Perkins, M. E. 1992. Rhoptry organelles of apicomplexan parasites. Parasi-
tol. Today 8:28–32.
38. Ridley, R. G., K. Takacs, H. Etlinger, and J. G. Scaife. 1990. A rhoptry
antigen of Plasmodium falciparum is protective in Saimiri monkeys. Parasi-
tology 101:187–192.
39. Rodriguez, S. D., G. H. Palmer, T. F. McElwain, T. C. McGuire, B. J. Ruef,
C. G. Chitko-McKown, and W. C. Brown. 1996. CD41 T-helper lymphocyte
responses against Babesia bigemina rhoptry-associated protein 1. Infect. Im-
mun. 64:2079–2087.
40. Schetters, T. P. M., and S. Montenegro-James. 1995. Vaccines against babe-
siosis using soluble parasite antigen. Parasitol. Today 11:456–462.
41. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin 12 induc-
tion of interferon g-dependent protection against malaria. Proc. Natl. Acad.
Sci. USA 91:10700–10702.
42. Siddiqui, W. A., L. Q. Tam, K. J. Kramer, G. S. N. Hui, S. E. Case,
K. M. Yamaga, S. P. Chang, E. B. T. Chan, and S. C. Kan. 1987. Mero-
zoite surface coat precursor protein completely protects Aotus monkeys
against Plasmodium falciparummalaria. Proc. Natl. Acad. Sci. USA 84:3014–
3018.
43. Suarez, C. E., T. F. McElwain, I. Echaide, S. Torioni de Echaide, and G. H.
Palmer. 1994. Interstrain conservation of babesial RAP-1 surface-exposed
B-cell epitopes despite rap-1 genomic polymorphism. Infect. Immun. 62:
2576–3579.
44. Suarez, C. E., T. F. McElwain, E. B. Stephens, V. S. Mishra, and G. H.
Palmer. 1991. Sequence conservation among merozoite apical complex pro-
teins of Babesia bovis, Babesia bigemina and other apicomplexa. Mol. Bio-
chem. Parasitol. 49:329–332.
45. Suarez, C. E., G. H. Palmer, S. A. Hines, and T. F. McElwain. 1993. Immu-
nogenic B-cell epitopes of Babesia bovis rhoptry-associated protein 1 are
distinct from sequences conserved between species. Infect. Immun. 61:3511–
3517.
46. Suarez, C. E., G. H. Palmer, D. P. Jasmer, S. A. Hines, L. E. Perryman, and
T. F. McElwain. 1991. Characterization of the gene encoding a 60-kilodalton
Babesia bovis merozoite protein with conserved and surface exposed epi-
topes. Mol. Biochem. Parasitol. 46:45–52.
47. Taylor-Robinson, A. W. 1995. Regulation of immunity to malaria: valuable
VOL. 64, 1996 B. BOVIS RAP-1 IS IMMUNODOMINANT FOR Th CELLS 3349
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
lessons learned from murine models. Parasitol. Today 11:334–342.
48. Taylor-Robinson, A. W., F. Y. Liew, A. Severn, D. Xu, S. J. McSorley, P.
Garside, J. Padron, and R. S. Phillips. 1994. Regulation of the immune
response by nitric oxide differentially produced by T helper type 1 and T
helper type 2 cells. Eur. J. Immunol. 24:980–984.
49. Tetzlaff, C. L., A. C. Rice-Ficht, V. M. Woods, and W. C. Brown. 1992.
Induction of proliferative responses of T cells from Babesia bovis-immune
cattle with a recombinant 77-kilodalton merozoite protein (Bb-1). Infect.
Immun. 60:644–652.
50. Tripp, C. L., G. G. Wagner, and A. C. Rice-Ficht. 1989. Babesia bovis: gene
isolation and characterization using a mung bean nuclease-derived expres-
sion library. Exp. Parasitol. 69:211–225.
51. Wright, I. G., R. Casu, M. A. Commins, B. P. Dalrymple, K. R. Gale, B. V.
Goodger, P. W. Riddles, D. J. Waltisbuhl, I. Abetz, D. A. Berrie, Y. Bowles,
C. Dimmock, T. Hayes, H. Kalnins, G. Leatch, R. McCrae, P. E. Montague,
I. T. Nisbet, F. Parrodi, J. M. Peters, P. C. Scheiwe, W. Smith, K. Rode-
Bramanis, and M. A. White. 1992. The development of a recombinant
Babesia vaccine. Vet. Parasitol. 44:3–13.
Editor: J. M. Mansfield
3350 BROWN ET AL. INFECT. IMMUN.
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
